Effects of Nutrition Meal Replacement and Individualized Exercise Prescription on Type 2 Diabetes
NCT ID: NCT02984605
Last Updated: 2016-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2016-12-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional group
Arm:Hypoglycemic agents + Nutrition meal replacement \& exercise prescription
Hypoglycemic agents in combined with 1 times a day with bags of nutritional meal replacement and exercise
nutritional meal replacement
1 times a day with bags of nutritional meal replacement + individualized exercise prescription
Control group
Arm:Hypoglycemic agents
without take nutrition meal replacement \& exercise prescription
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nutritional meal replacement
1 times a day with bags of nutritional meal replacement + individualized exercise prescription
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be able to swallow tablets
Exclusion Criteria
* Thyroid disease
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai University of Sports National Science Park
UNKNOWN
Yinhang Community Health Service Center of Yangpu District
UNKNOWN
Dinghai Community Health Service Center of Yangpu District
UNKNOWN
Kongjiang Community Health Service Center of Yangpu District
UNKNOWN
Daqiao Community Health Service Center of Yangpu District
UNKNOWN
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ming Cui, MD
Role: PRINCIPAL_INVESTIGATOR
YinXing Community Health Service Center of Yangpu District
Wenbin Liu, MD
Role: PRINCIPAL_INVESTIGATOR
Dinghai Community Health Service Center of Yangpu District
Xiaoyi Che, MD
Role: PRINCIPAL_INVESTIGATOR
Kongjiang Community Health Service Center of Yangpu District
Hui Liu, MD
Role: PRINCIPAL_INVESTIGATOR
Daqiao Community Health Service Center of Yangpu District
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XH-16-046
Identifier Type: -
Identifier Source: org_study_id